FDA 510(k)

XPER Technology PREMIUM Pro Blood Glucose Monitoring System

K-Number: K221349 · 2024-11-19

Decision Date2024-11-19

Product CodePZI

Advisory CommitteeCH

DecisionSubstantially Equivalent

Device Summary

XPER Technology PREMIUM Pro Blood Glucose Monitoring System is a medical device manufactured by Taidoc Technology Corporation. It received FDA 510(k) clearance on 2024-11-19 under approval number K221349. The device is classified under product code PZI. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the XPER Technology PREMIUM Pro Blood Glucose Monitoring System?

XPER Technology PREMIUM Pro Blood Glucose Monitoring System is a medical device that received FDA 510(k) clearance on 2024-11-19. It is manufactured by Taidoc Technology Corporation. The 510(k) number is K221349.

When was XPER Technology PREMIUM Pro Blood Glucose Monitoring System approved by the FDA?

XPER Technology PREMIUM Pro Blood Glucose Monitoring System received FDA 510(k) clearance on 2024-11-19, under approval number K221349.

What company makes XPER Technology PREMIUM Pro Blood Glucose Monitoring System?

XPER Technology PREMIUM Pro Blood Glucose Monitoring System is manufactured by Taidoc Technology Corporation.

What is the FDA product code for XPER Technology PREMIUM Pro Blood Glucose Monitoring System?

The FDA product code for XPER Technology PREMIUM Pro Blood Glucose Monitoring System is PZI.

Related Clinical Trials

NCT01143558 Searching for Persistence of Infection in Lyme Disease COMPLETED NCT07614139 Continuous Glucose Monitoring Alerts, Accuracy, and Patient Outcomes in Adults With Inherited Metabolic Disorders COMPLETED NCT06727942 Virtual Reality-Infused Treadmill Training on Aging-Related Outcomes RECRUITING NCT01143454 Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System RECRUITING NCT01174108 Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells RECRUITING NCT07614100 Cerebral Microembolization During Transcatheter Aortic Valve Implantation: Comparing Balloon-expandable and Self-expanding Valves NOT_YET_RECRUITING

Related PubMed Literature

PMID: 42174947 Aligning AI-Native 6G Healthcare Systems with EU Ethical and Legal Frameworks. Studies in health technology and informatics (2026) PMID: 41966529 Comparison of the AccuPower HIV-1 Quant Kit and Aptima HIV-1 Quant Dx Assay for quantification of HIV-1 plasma viral load. Diagnostic microbiology and infectious disease (2026) PMID: 41964171 Journal of diabetes science and technology (2026) PMID: 41887630 Capacity building for ethical use of artificial intelligence in health: protocol for a scoping review of training initiatives and gaps in Africa. BMJ open (2026)

Other Devices by Taidoc Technology Corporation

K161738FORA ADVANCED GD40 and FORA ADVANCED GD40 pro Blood Glucose and ß-Ketone Monitoring Systems K152680TD-1035 Thermometer K151024Finger Type Pulse Oximeter K142664URight Hemoglobin A1c system, FORA A1c System K162382Smart Dongle Blood Glucose Monitoring System K180863FORA NAS100 Electronic Nasal Aspirator, Electronic Nasal Aspirator

View all 17 devices →

Related Devices (Code: PZI)

K161856StatStrip Xpress Glucose Hospital Meter SystemNova Biomedical Corporation K152986StatStrip Xpress 2 Glucose Hospital Meter SystemNova Biomedical Corporation K163490StatStrip Xpress 2 Glucose Hospital Meter SystemNova Biomedical Corporation K182552StatStrip Xpress Glucose Hospital Meter SystemNova Biomedical Corporation K182549StatStrip Xpress 2 Glucose Hospital Meter SystemNova Biomedical Corporation K181043StatStrip Glucose Hospital Meter SystemNova Biomedical Corporation

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.